Correlation Between Small Pharma and BiOasis Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Small Pharma and BiOasis Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Small Pharma and BiOasis Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Small Pharma and biOasis Technologies, you can compare the effects of market volatilities on Small Pharma and BiOasis Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Small Pharma with a short position of BiOasis Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Small Pharma and BiOasis Technologies.

Diversification Opportunities for Small Pharma and BiOasis Technologies

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Small and BiOasis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Small Pharma and biOasis Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on biOasis Technologies and Small Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Small Pharma are associated (or correlated) with BiOasis Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of biOasis Technologies has no effect on the direction of Small Pharma i.e., Small Pharma and BiOasis Technologies go up and down completely randomly.

Pair Corralation between Small Pharma and BiOasis Technologies

Assuming the 90 days horizon Small Pharma is expected to generate 14.92 times less return on investment than BiOasis Technologies. But when comparing it to its historical volatility, Small Pharma is 3.13 times less risky than BiOasis Technologies. It trades about 0.01 of its potential returns per unit of risk. biOasis Technologies is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  12.00  in biOasis Technologies on August 29, 2024 and sell it today you would lose (11.99) from holding biOasis Technologies or give up 99.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy31.52%
ValuesDaily Returns

Small Pharma  vs.  biOasis Technologies

 Performance 
       Timeline  
Small Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Small Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Small Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
biOasis Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days biOasis Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, BiOasis Technologies is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Small Pharma and BiOasis Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Small Pharma and BiOasis Technologies

The main advantage of trading using opposite Small Pharma and BiOasis Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Small Pharma position performs unexpectedly, BiOasis Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiOasis Technologies will offset losses from the drop in BiOasis Technologies' long position.
The idea behind Small Pharma and biOasis Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine